Medicine Information

Vioxx Personal Injury Lawsuits


Personal injury attorneys representing clients who have allegedly been harmed by the prescription drug Vioxx are congratulating themselves over a historic judgment rendered recently. On August 19, 2005, a judge awarded the family of Bob Ernst $253.4 million due to his death from the drug. Vioxx, which had been prescribed most often for arthritis pain, was withdrawn globally by its maker, Merck, after research trials showed it increased patients' chances of a heart attack. Although Merck pulled the drug off the market in September 2004, legal action against this leading pharmaceutical giant will continue and expand. Let's take a look at why Vioxx has become a litigation lightning rod.

In 1998 as Merck was running clinical trials for Vioxx, company reports to the FDA stated that there were no cardiovascular signals apparent. This meant that there were no telltale signs that the drug could cause heart problems for users. Later, however, it was revealed that an internal study conducted by Merck around the same time - Study 090 - revealed serious cardiovascular problems as compared to patients not taking Vioxx. The study was never published by Merck as the company insisted that it was not large enough to provide definitive data.

The following year the FDA gave Vioxx its approval and the drug became the second nonsteroidal anti-inflammatory medication [or COX-2 inhibitor] to hit the market. Celebrex, another problem drug, was the first.

Merck widely and thoroughly launched a marketing campaign upon the introduction of Vioxx to the marketplace. Indeed, by 2003 the drug had entered 80 nations with sales exceeding $2.5 billion. Still, there were problems looming as ongoing tests conducted by Merck hinted of potential deadly side effects.

As early as 2001, the FDA recommended label warnings be put on prescriptions warning users of potential side effects. In addition, Merck was warned by the FDA to quit misleading physicians about potential side effects.

As potential problems began to surface, they served as red flags to industry watchdogs, to the FDA, as well as to personal injury attorneys who began to gather evidence to show that Merck was negligent. Indeed, web sites and advertising campaigns - meant to inform and attract patients harmed by the drug - were launched and fairly soon the internet, radio, television, and print media were flooded with advertisements asking those suspecting harm from Vioxx to come forward.

With the September 2004 announcement that Merck was withdrawing Vioxx, personal injury litigation was well on its way to being established. By early 2005, the first cases were filed and the Ernst case became the first Vioxx lawsuit to be settled.

Wrongful death lawsuits against Vioxx's maker, Merck, are expected to increase as the result of the Ernst decision. Personal injury attorneys insist that thousands of former Vioxx users and/or their families are due compensation for Merck's neglect. It remains to be seen if juries will render judgments as large as the Ernst judgment and whether courts will uphold these amounts. Nevertheless, it is certain that Merck is in for a long battle that will reach well beyond its US base.

Matthew Keegan is The Article Writer who writes on just about any and every issue imaginable. You can preview samples from his high performing site at http://www.thearticlewriter.com


MORE RESOURCES:

Spoonful of Sugar Really Might Help Medicine Go Down
U.S. News & World Report, DC - 3 hours ago
21 (HealthDay News) -- If your child won't take medicine and shuns broccoli at the dinner table, his body may just be hard-wired to respond that way. ...


Insurance gap leads some elderly to forgo medicine
The Associated Press - 7 hours ago
WASHINGTON (AP) — Many people in Medicare with diabetes, high blood pressure and other chronic conditions stop taking their medicine when faced with picking ...
Health care panel at WSU pushes for system overhaul Detroit Free Press
all 103 news articles


Helping the medicine go down
EurekAlert (press release), DC - 3 hours ago
21, 2008 — Getting little Doug and Debbie to take a spoonful of medicine is more than just a rite of passage for frustrated parents. ...


Stanley Deresinski, Clinical Professor of Medicine-Med/Infectious ...
PR.com (press release), NY - 3 hours ago
Monrovia, CA, August 21, 2008 --(PR.com)-- Dr. Stanley Deresinski, Clinical Professor of Medicine-Med/Infectious Diseases at Stanford University in Palo ...


Insurance gap leads some elderly to forgo medicine
WLOS, NC - 6 hours ago
WASHINGTON (AP) -- Researchers say that when many people who enrolled in Medicare hit what's called the "doughnut hole," they stop taking their medicines. ...


The New England Journal of Medicine, American Family Physician ...
Earthtimes (press release), UK - 9 hours ago
21 -- The New England Journal of Medicine and American Family Physician rank as top online medical journals by US primary care physician visitation, ...


Alternative medicine will be on display
The Gazette (Montreal), Canada - 13 hours ago
It is truly amazing to see how mainstream and accepted alternative medicine has become. I remember when I first started to seek out alternative treatments ...


New York Times

Merck Comments on New England Journal of Medicine article by J ...
PharmaLive.com (press release), PA - 8 hours ago
Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. ...
Get your young virgins vaccinated against HPV and cancer ZDNet
HPV vaccine by age 21 is a sound investment USA Today
Cervical cancer vaccine in doubt Irish Medical Times
Irish Times - Wall Street Journal Blogs
all 314 news articles


AFP

Anti-addiction medicine leads to weight loss in rats: study
AFP - 5 hours ago
WASHINGTON (AFP) — A medicine seen as a promising treatment for cocaine and methamphetamine addiction has also been shown to shed weight in laboratory rats, ...


BBC News

Cutting edge medicine examined
BBC News, UK - 13 hours ago
Patients, doctors and scientists at the cutting edge of medicine are the subject of a new programme. The first programme on robotic surgery looks at how an ...

Medicine - Google News

home | site map
© 2006